POSTERS
The cost-effectiveness of Axicabtagene Ciloleucel versus standard of care as second-line therapy in patients with large B-cell lymphoma in AUSTRALIA
LHC Author: Michael Aristides
Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal chondral defects of the knee – an Australian perspective
LHC Author: George Papadopoulos
Cost Utility and Budget Impact Analyses of Closed Loop Upper Airway Stimulation (UAS) for the Treatment of Moderate to Severe Obstructive Sleep Apnea from an Australian Health Care System Perspective
LHC Author: George Papadopoulos
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.